Manns B - Search Results

1

Multiple versus single and other estimates of baseline proteinuria status as predictors of adverse outcomes in the general population.

Bello A, Thompson S, Lloyd A, Hemmelgarn B, Klarenbach S, Manns B, Tonelli M; Alberta Kidney Disease Network. Bello A, et al. Among authors: manns b. Am J Kidney Dis. 2012 Mar;59(3):364-71. doi: 10.1053/j.ajkd.2011.09.006. Epub 2011 Nov 5. Am J Kidney Dis. 2012. PMID: 22056391

2

Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.

Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C. Lee H, et al. Among authors: manns b. Am J Kidney Dis. 2002 Sep;40(3):611-22. doi: 10.1053/ajkd.2002.34924. Am J Kidney Dis. 2002. PMID: 12200814

3

Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery.

Tonelli M, Manns B, Feller-Kopman D. Tonelli M, et al. Among authors: manns b. Am J Kidney Dis. 2002 Nov;40(5):875-85. doi: 10.1053/ajkd.2002.36318. Am J Kidney Dis. 2002. PMID: 12407631 Review.

4

Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery.

Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D, Donaldson C. Manns B, et al. Crit Care Med. 2003 Feb;31(2):449-55. doi: 10.1097/01.CCM.0000045182.90302.B3. Crit Care Med. 2003. PMID: 12576950

5

Influence of dialysis membranes on outcomes in acute renal failure.

Tonelli M, Pannu N, Manns B. Tonelli M, et al. Among authors: manns b. Kidney Int. 2003 May;63(5):1957-8; author reply 1958. doi: 10.1046/j.1523-1755.2003.00948.x. Kidney Int. 2003. PMID: 12675882 Free article. No abstract available.

6

The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients.

Tonelli M, Winkelmayer WC, Jindal KK, Owen WF, Manns BJ. Tonelli M, et al. Kidney Int. 2003 Jul;64(1):295-304. doi: 10.1046/j.1523-1755.2003.00079.x. Kidney Int. 2003. PMID: 12787422 Free article.

7

Adapting the Charlson Comorbidity Index for use in patients with ESRD.

Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Hemmelgarn BR, et al. Am J Kidney Dis. 2003 Jul;42(1):125-32. doi: 10.1016/s0272-6386(03)00415-3. Am J Kidney Dis. 2003. PMID: 12830464

8

Systematic review of the impact of N-acetylcysteine on contrast nephropathy.

Pannu N, Manns B, Lee H, Tonelli M. Pannu N, et al. Among authors: manns b. Kidney Int. 2004 Apr;65(4):1366-74. doi: 10.1111/j.1523-1755.2004.00516.x. Kidney Int. 2004. PMID: 15086476 Free article. Review.

9

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.

Manns B, Stevens L, Miskulin D, Owen WF Jr, Winkelmayer WC, Tonelli M. Manns B, et al. Kidney Int. 2004 Sep;66(3):1239-47. doi: 10.1111/j.1523-1755.2004.00877.x. Kidney Int. 2004. PMID: 15327423 Free article. Review.

10

Death and renal transplantation among Aboriginal people undergoing dialysis.

Tonelli M, Hemmelgarn B, Manns B, Pylypchuk G, Bohm C, Yeates K, Gourishankar S, Gill JS. Tonelli M, et al. Among authors: manns b. CMAJ. 2004 Sep 14;171(6):577-82. doi: 10.1503/cmaj.1031859. CMAJ. 2004. PMID: 15367459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters